Glaxosmithkline | Capital De Empréstimo



Loan Capital Alterar Data
AbbVie USD 60.34B 1.83B 2024-12
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Indivior 311M 4M 2025-03
J&J USD 38.36B 7.7B 2025-03
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.64B 234M 2025-03
Prestige Brands USD 1.01B 16.93M 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 3.97T 738.36B 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Zoetis USD 5.23B 7M 2025-03



Glaxosmithkline Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.